Long term Evaluation of Dabigatran 150 versus 110 mg BID in Patients with Non-Valvular Atrial Fibrillation
Autoren
Ezekowitz MD, DPhil, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Kent AP, Pogue J, Spahr J, Clemens A, Noack H, Diener H-C, Wallentin L, Yusuf S, Connolly SJ
Journal
Europace
Veröffentlichungsdatum
2016
Impact Factor
3.670
Abstract
Weitere IDs
Long term Evaluation of Dabigatran 150 versus 110 mg BID in Patients with Non-Valvular Atrial Fibrillation - Publikation von Dr. Andreas Clemens | Dr. Andreas Clemens